MENU
ITOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
iTeos Therapeutics (ITOS) Ownership - Who owns iTeos Therapeutics?
Profile
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
270.35M
P/E Ratio
N/A
Total Cash
488.71M
Projected Growth
N/A
Total Debt
5.53M
Revenue
35M
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
13.38
Total Debt/Equity
N/A
Revenue/Share
0.91 USD as % of share price
Fundamentals
ITOS
Capitalization
270M
P/E Ratio
N/A
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash
489M
Total Cash/Share
13.38
Total Debt
5.53M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.91%
Revenue
35M
ROE
N/A
Book Value
632M
P/B Ratio
0.43
Cash Flow
N/A
Earnings
-3.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
37K
Current Ratio
14.80
Current Revenue Per Employee
222929.94
Dividends Per Share - Security
N/A
EBITDA
-142.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.31
Shares Held By Institutions
1.5B
Shares Outstanding - Current
36.5M
Total Liabilities
91.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-32.420
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biopharmaceuticals therapeutic products and services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com